Asset Dedication’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Asset Dedication's TEVA Position: Q3 2026 in Review
Asset Dedication sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 198 shares — an estimated $6.71K sold.
Asset Dedication first reported a position in TEVA in Q4 2015 and held it in 3 quarters. The position peaked at $6.71K in Q2 2026. 477 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Asset Dedication reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
- Asset Dedication sold 198 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $6.71K.
- Asset Dedication first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 3 quarters.
- Asset Dedication's Teva Pharmaceutical Industries Limited position peaked at $6.71K in Q2 2026.
- 477 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.